HEADER TRANSCRIPTION 09-OCT-19 6L36 TITLE X-RAY STRUCTURE OF HUMAN PPARALPHA LIGAND BINDING DOMAIN-GW9662- TITLE 2 FENOFIBRIC ACID CO-CRYSTALS OBTAINED BY DELIPIDATION AND CO- TITLE 3 CRYSTALLIZATION COMPND MOL_ID: 1; COMPND 2 MOLECULE: PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR ALPHA; COMPND 3 CHAIN: A, B; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_TAXID: 9606; SOURCE 4 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 5 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 6 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 7 EXPRESSION_SYSTEM_PLASMID: PET28A KEYWDS NUCLEAR RECEPTOR, PROTEIN-LIGAND COMPLEX, PPAR, TRANSCRIPTION EXPDTA X-RAY DIFFRACTION AUTHOR S.KAMATA,K.SAITO,A.HONDA,R.ISHIKAWA,T.OYAMA,I.ISHII REVDAT 3 22-NOV-23 6L36 1 REMARK REVDAT 2 02-DEC-20 6L36 1 JRNL REVDAT 1 11-NOV-20 6L36 0 JRNL AUTH S.KAMATA,T.OYAMA,K.SAITO,A.HONDA,Y.YAMAMOTO,K.SUDA, JRNL AUTH 2 R.ISHIKAWA,T.ITOH,Y.WATANABE,T.SHIBATA,K.UCHIDA,M.SUEMATSU, JRNL AUTH 3 I.ISHII JRNL TITL PPAR ALPHA LIGAND-BINDING DOMAIN STRUCTURES WITH ENDOGENOUS JRNL TITL 2 FATTY ACIDS AND FIBRATES. JRNL REF ISCIENCE V. 23 01727 2020 JRNL REFN ESSN 2589-0042 JRNL PMID 33205029 JRNL DOI 10.1016/J.ISCI.2020.101727 REMARK 2 REMARK 2 RESOLUTION. 3.30 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.11.1-2575-000 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.30 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 40.35 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.950 REMARK 3 COMPLETENESS FOR RANGE (%) : 97.6 REMARK 3 NUMBER OF REFLECTIONS : 11364 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.194 REMARK 3 R VALUE (WORKING SET) : 0.190 REMARK 3 FREE R VALUE : 0.250 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.400 REMARK 3 FREE R VALUE TEST SET COUNT : 1176 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 3.4508 - 3.3010 0.98 2584 140 0.2943 0.3372 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.350 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 27.340 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : NULL NULL REMARK 3 ANGLE : NULL NULL REMARK 3 CHIRALITY : NULL NULL REMARK 3 PLANARITY : NULL NULL REMARK 3 DIHEDRAL : NULL NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: SF FILE CONTAINS FRIEDEL PAIRS UNDER REMARK 3 I/F_MINUS AND I/F_PLUS COLUMNS. REMARK 4 REMARK 4 6L36 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 10-OCT-19. REMARK 100 THE DEPOSITION ID IS D_1300013868. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 05-DEC-18 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : PHOTON FACTORY REMARK 200 BEAMLINE : BL-17A REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.00000 REMARK 200 MONOCHROMATOR : SI(111) REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER X 16M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS 0.5.21 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 11392 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.300 REMARK 200 RESOLUTION RANGE LOW (A) : 46.310 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 200 DATA REDUNDANCY : 3.500 REMARK 200 R MERGE (I) : 0.06300 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 14.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.30 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.57 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.6 REMARK 200 DATA REDUNDANCY IN SHELL : 3.60 REMARK 200 R MERGE FOR SHELL (I) : 0.31400 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 4.300 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER 2.7.16 REMARK 200 STARTING MODEL: 3VI8 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 60.39 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.11 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M TRIS (PH 8.0), 25 %(W/V) REMARK 280 PEG3350, VAPOR DIFFUSION, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 51.27500 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 196 REMARK 465 SER A 197 REMARK 465 HIS A 198 REMARK 465 MET A 199 REMARK 465 GLY B 196 REMARK 465 SER B 197 REMARK 465 HIS B 198 REMARK 465 MET B 199 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 232 CD CE NZ REMARK 470 LYS A 266 CG CD CE NZ REMARK 470 ASP A 453 CB CG OD1 OD2 REMARK 470 THR B 200 OG1 CG2 REMARK 470 LEU B 203 CG CD1 CD2 REMARK 470 LYS B 232 CG CD CE NZ REMARK 470 ILE B 263 CG1 CG2 CD1 REMARK 470 GLN B 264 CG CD OE1 NE2 REMARK 470 LEU B 302 CG CD1 CD2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 SG CYS B 275 C10 GW9 B 502 1.73 REMARK 500 OH TYR B 314 O03 F5A B 504 2.14 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A 201 -60.12 -160.34 REMARK 500 ILE A 263 -86.48 -62.10 REMARK 500 GLN A 264 -82.83 38.76 REMARK 500 THR A 450 -68.02 -125.92 REMARK 500 MET A 467 -72.61 -73.97 REMARK 500 SER B 234 138.84 179.44 REMARK 500 GLN B 264 64.19 -65.46 REMARK 500 ASN B 265 -35.17 175.99 REMARK 500 LYS B 266 171.60 -59.06 REMARK 500 CYS B 384 36.82 -87.26 REMARK 500 ASP B 387 46.56 -106.31 REMARK 500 LEU B 392 -71.81 -110.46 REMARK 500 PHE B 421 33.89 -89.17 REMARK 500 LYS B 449 62.77 -102.34 REMARK 500 THR B 450 -35.26 -175.17 REMARK 500 SER B 452 -79.37 23.92 REMARK 500 ASP B 453 -45.66 -169.16 REMARK 500 ALA B 454 -8.86 60.91 REMARK 500 LEU B 456 113.75 -16.56 REMARK 500 HIS B 457 137.41 -39.91 REMARK 500 MET B 467 -91.14 -104.02 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GW9 A 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GW9 A 502 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GW9 A 503 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue F5A A 504 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue F5A B 504 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide GW9 B 501 and CYS B REMARK 800 276 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide GW9 B 502 and CYS B REMARK 800 275 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide GW9 B 502 and CYS B REMARK 800 275 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide GW9 B 503 and CYS B REMARK 800 278 DBREF 6L36 A 200 468 UNP Q07869 PPARA_HUMAN 200 468 DBREF 6L36 B 200 468 UNP Q07869 PPARA_HUMAN 200 468 SEQADV 6L36 GLY A 196 UNP Q07869 EXPRESSION TAG SEQADV 6L36 SER A 197 UNP Q07869 EXPRESSION TAG SEQADV 6L36 HIS A 198 UNP Q07869 EXPRESSION TAG SEQADV 6L36 MET A 199 UNP Q07869 EXPRESSION TAG SEQADV 6L36 GLY B 196 UNP Q07869 EXPRESSION TAG SEQADV 6L36 SER B 197 UNP Q07869 EXPRESSION TAG SEQADV 6L36 HIS B 198 UNP Q07869 EXPRESSION TAG SEQADV 6L36 MET B 199 UNP Q07869 EXPRESSION TAG SEQRES 1 A 273 GLY SER HIS MET THR ALA ASP LEU LYS SER LEU ALA LYS SEQRES 2 A 273 ARG ILE TYR GLU ALA TYR LEU LYS ASN PHE ASN MET ASN SEQRES 3 A 273 LYS VAL LYS ALA ARG VAL ILE LEU SER GLY LYS ALA SER SEQRES 4 A 273 ASN ASN PRO PRO PHE VAL ILE HIS ASP MET GLU THR LEU SEQRES 5 A 273 CYS MET ALA GLU LYS THR LEU VAL ALA LYS LEU VAL ALA SEQRES 6 A 273 ASN GLY ILE GLN ASN LYS GLU ALA GLU VAL ARG ILE PHE SEQRES 7 A 273 HIS CYS CYS GLN CYS THR SER VAL GLU THR VAL THR GLU SEQRES 8 A 273 LEU THR GLU PHE ALA LYS ALA ILE PRO GLY PHE ALA ASN SEQRES 9 A 273 LEU ASP LEU ASN ASP GLN VAL THR LEU LEU LYS TYR GLY SEQRES 10 A 273 VAL TYR GLU ALA ILE PHE ALA MET LEU SER SER VAL MET SEQRES 11 A 273 ASN LYS ASP GLY MET LEU VAL ALA TYR GLY ASN GLY PHE SEQRES 12 A 273 ILE THR ARG GLU PHE LEU LYS SER LEU ARG LYS PRO PHE SEQRES 13 A 273 CYS ASP ILE MET GLU PRO LYS PHE ASP PHE ALA MET LYS SEQRES 14 A 273 PHE ASN ALA LEU GLU LEU ASP ASP SER ASP ILE SER LEU SEQRES 15 A 273 PHE VAL ALA ALA ILE ILE CYS CYS GLY ASP ARG PRO GLY SEQRES 16 A 273 LEU LEU ASN VAL GLY HIS ILE GLU LYS MET GLN GLU GLY SEQRES 17 A 273 ILE VAL HIS VAL LEU ARG LEU HIS LEU GLN SER ASN HIS SEQRES 18 A 273 PRO ASP ASP ILE PHE LEU PHE PRO LYS LEU LEU GLN LYS SEQRES 19 A 273 MET ALA ASP LEU ARG GLN LEU VAL THR GLU HIS ALA GLN SEQRES 20 A 273 LEU VAL GLN ILE ILE LYS LYS THR GLU SER ASP ALA ALA SEQRES 21 A 273 LEU HIS PRO LEU LEU GLN GLU ILE TYR ARG ASP MET TYR SEQRES 1 B 273 GLY SER HIS MET THR ALA ASP LEU LYS SER LEU ALA LYS SEQRES 2 B 273 ARG ILE TYR GLU ALA TYR LEU LYS ASN PHE ASN MET ASN SEQRES 3 B 273 LYS VAL LYS ALA ARG VAL ILE LEU SER GLY LYS ALA SER SEQRES 4 B 273 ASN ASN PRO PRO PHE VAL ILE HIS ASP MET GLU THR LEU SEQRES 5 B 273 CYS MET ALA GLU LYS THR LEU VAL ALA LYS LEU VAL ALA SEQRES 6 B 273 ASN GLY ILE GLN ASN LYS GLU ALA GLU VAL ARG ILE PHE SEQRES 7 B 273 HIS CYS CYS GLN CYS THR SER VAL GLU THR VAL THR GLU SEQRES 8 B 273 LEU THR GLU PHE ALA LYS ALA ILE PRO GLY PHE ALA ASN SEQRES 9 B 273 LEU ASP LEU ASN ASP GLN VAL THR LEU LEU LYS TYR GLY SEQRES 10 B 273 VAL TYR GLU ALA ILE PHE ALA MET LEU SER SER VAL MET SEQRES 11 B 273 ASN LYS ASP GLY MET LEU VAL ALA TYR GLY ASN GLY PHE SEQRES 12 B 273 ILE THR ARG GLU PHE LEU LYS SER LEU ARG LYS PRO PHE SEQRES 13 B 273 CYS ASP ILE MET GLU PRO LYS PHE ASP PHE ALA MET LYS SEQRES 14 B 273 PHE ASN ALA LEU GLU LEU ASP ASP SER ASP ILE SER LEU SEQRES 15 B 273 PHE VAL ALA ALA ILE ILE CYS CYS GLY ASP ARG PRO GLY SEQRES 16 B 273 LEU LEU ASN VAL GLY HIS ILE GLU LYS MET GLN GLU GLY SEQRES 17 B 273 ILE VAL HIS VAL LEU ARG LEU HIS LEU GLN SER ASN HIS SEQRES 18 B 273 PRO ASP ASP ILE PHE LEU PHE PRO LYS LEU LEU GLN LYS SEQRES 19 B 273 MET ALA ASP LEU ARG GLN LEU VAL THR GLU HIS ALA GLN SEQRES 20 B 273 LEU VAL GLN ILE ILE LYS LYS THR GLU SER ASP ALA ALA SEQRES 21 B 273 LEU HIS PRO LEU LEU GLN GLU ILE TYR ARG ASP MET TYR HET GW9 A 501 27 HET GW9 A 502 27 HET GW9 A 503 27 HET F5A A 504 36 HET GW9 B 501 27 HET GW9 B 502 27 HET GW9 B 503 27 HET F5A B 504 36 HETNAM GW9 2-CHLORO-5-NITRO-N-PHENYLBENZAMIDE HETNAM F5A 2-[4-(4-CHLOROBENZENE-1-CARBONYL)PHENOXY]-2- HETNAM 2 F5A METHYLPROPANOIC ACID FORMUL 3 GW9 6(C13 H9 CL N2 O3) FORMUL 6 F5A 2(C17 H15 CL O4) HELIX 1 AA1 ALA A 201 PHE A 218 1 18 HELIX 2 AA2 ASN A 221 GLY A 231 1 11 HELIX 3 AA3 ASP A 243 LEU A 254 1 12 HELIX 4 AA4 LEU A 254 ALA A 260 1 7 HELIX 5 AA5 GLU A 267 ALA A 291 1 25 HELIX 6 AA6 LYS A 292 ILE A 294 5 3 HELIX 7 AA7 ASP A 301 SER A 322 1 22 HELIX 8 AA8 SER A 323 MET A 325 5 3 HELIX 9 AA9 ARG A 341 LEU A 347 1 7 HELIX 10 AB1 PRO A 350 ILE A 354 5 5 HELIX 11 AB2 MET A 355 ALA A 367 1 13 HELIX 12 AB3 ASP A 371 CYS A 384 1 14 HELIX 13 AB4 ASN A 393 HIS A 416 1 24 HELIX 14 AB5 PHE A 421 LYS A 449 1 29 HELIX 15 AB6 HIS A 457 ARG A 465 1 9 HELIX 16 AB7 ALA B 201 PHE B 218 1 18 HELIX 17 AB8 ASN B 221 GLY B 231 1 11 HELIX 18 AB9 ASP B 243 LYS B 252 1 10 HELIX 19 AC1 LEU B 254 ALA B 260 1 7 HELIX 20 AC2 GLU B 267 ALA B 291 1 25 HELIX 21 AC3 LYS B 292 ILE B 294 5 3 HELIX 22 AC4 ASP B 301 SER B 322 1 22 HELIX 23 AC5 SER B 323 MET B 325 5 3 HELIX 24 AC6 ARG B 341 LEU B 347 1 7 HELIX 25 AC7 PRO B 350 ILE B 354 5 5 HELIX 26 AC8 MET B 355 LEU B 368 1 14 HELIX 27 AC9 ASP B 371 CYS B 384 1 14 HELIX 28 AD1 ASN B 393 HIS B 416 1 24 HELIX 29 AD2 PHE B 421 LYS B 449 1 29 HELIX 30 AD3 HIS B 457 ARG B 465 1 9 SHEET 1 AA1 3 PHE A 239 ILE A 241 0 SHEET 2 AA1 3 GLY A 337 THR A 340 1 O THR A 340 N ILE A 241 SHEET 3 AA1 3 GLY A 329 VAL A 332 -1 N VAL A 332 O GLY A 337 SHEET 1 AA2 3 PHE B 239 ILE B 241 0 SHEET 2 AA2 3 GLY B 337 THR B 340 1 O PHE B 338 N ILE B 241 SHEET 3 AA2 3 GLY B 329 VAL B 332 -1 N VAL B 332 O GLY B 337 LINK SG CYS A 275 C9 GW9 A 502 1555 1555 1.80 LINK SG CYS A 276 C9 GW9 A 501 1555 1555 1.80 LINK SG CYS A 278 C9 GW9 A 503 1555 1555 1.80 LINK SG CYS B 275 C9 GW9 B 502 1555 1555 1.81 LINK SG CYS B 276 C9 GW9 B 501 1555 1555 1.80 LINK SG CYS B 278 C9 GW9 B 503 1555 1555 1.80 CISPEP 1 LYS A 349 PRO A 350 0 -0.03 CISPEP 2 LYS B 349 PRO B 350 0 -0.94 SITE 1 AC1 7 ILE A 241 CYS A 276 THR A 279 LEU A 321 SITE 2 AC1 7 MET A 330 VAL A 332 GW9 A 502 SITE 1 AC2 8 ALA A 250 GLU A 251 LEU A 254 CYS A 275 SITE 2 AC2 8 THR A 279 ALA A 333 TYR A 334 GW9 A 501 SITE 1 AC3 10 LYS A 257 LEU A 258 ASN A 261 ILE A 263 SITE 2 AC3 10 HIS A 274 CYS A 275 CYS A 278 ALA A 455 SITE 3 AC3 10 LEU A 456 HIS A 457 SITE 1 AC4 11 GLN A 277 SER A 280 TYR A 314 HIS A 440 SITE 2 AC4 11 VAL A 444 ILE A 447 LYS A 448 ALA A 454 SITE 3 AC4 11 ALA A 455 LEU A 456 TYR A 464 SITE 1 AC5 13 PHE B 273 CYS B 276 SER B 280 TYR B 314 SITE 2 AC5 13 HIS B 440 VAL B 444 ILE B 447 LYS B 448 SITE 3 AC5 13 ASP B 453 ALA B 454 LEU B 456 LEU B 460 SITE 4 AC5 13 TYR B 464 SITE 1 AC6 13 ILE B 241 ILE B 272 PHE B 273 HIS B 274 SITE 2 AC6 13 CYS B 275 GLN B 277 CYS B 278 THR B 279 SITE 3 AC6 13 SER B 280 LEU B 321 VAL B 332 GW9 B 502 SITE 4 AC6 13 F5A B 504 SITE 1 AC7 13 PHE A 421 ALA B 250 LEU B 254 LYS B 257 SITE 2 AC7 13 ARG B 271 ILE B 272 HIS B 274 CYS B 276 SITE 3 AC7 13 GLN B 277 CYS B 278 THR B 279 GW9 B 501 SITE 4 AC7 13 GW9 B 503 SITE 1 AC8 13 PHE A 421 ALA B 250 LEU B 254 LYS B 257 SITE 2 AC8 13 ARG B 271 ILE B 272 HIS B 274 CYS B 276 SITE 3 AC8 13 GLN B 277 CYS B 278 THR B 279 GW9 B 501 SITE 4 AC8 13 GW9 B 503 SITE 1 AC9 14 LEU B 254 LYS B 257 LEU B 258 ASN B 261 SITE 2 AC9 14 HIS B 274 CYS B 275 CYS B 276 GLN B 277 SITE 3 AC9 14 THR B 279 SER B 280 VAL B 281 GLU B 282 SITE 4 AC9 14 ALA B 455 HIS B 457 CRYST1 60.773 102.550 62.087 90.00 97.86 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.016455 0.000000 0.002272 0.00000 SCALE2 0.000000 0.009751 0.000000 0.00000 SCALE3 0.000000 0.000000 0.016259 0.00000